Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
Provider: Reuters Investment Profile
Provider: Pechala's Reports
Provider: Pechala's Reports

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Merus Labs International Inc announces $22.1 million bought deal financing

Wednesday, 11 Jun 2014 04:19pm EDT 

Merus Labs International Inc:Enters into agreement with syndicate of investment dealers co-led by Canaccord Genuity Corp., Clarus Securities Inc. and Cormark Securities Inc. (Underwriters).Pursuant to which Underwriters have agreed to purchase 13,000,000 common shares (Shares) from treasury of Company, at price of $1.70 per Share for aggregate gross proceeds of $22,100,000 and offer them to the public by way of prospectus supplement (Offering).In addition, the Company has granted the Underwriters an option (Over-Allotment Option) to purchase up to an additional 1,950,000 Shares from the treasury of company at offering price exercisable at any time up to 30 days following Closing.Net proceeds of the Offering will be used for future acquisitions and general working capital. 

Company Quote

0.01 +0.47%
2 Mar 2015